Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia

Figure 1

Flow cytometric quantifications of circulating numbers of endothelial progenitor cells (EPCs) at 18 h and day 21 after critical limb ischemia (CLI) procedure (n = 8). A &B) circulating number of C-kit/CD31+ cells at 18 h and day 21. By day 21,* vs. other groups with different symbols (i.e.,* vs. † vs. ‡), p < 0.001. C &D) circulating number of Sca-1/CD31+ cells at 18 h and day 21. At 18 h,* vs. other groups with different symbols, p < 0.008. At day 21,* vs. other groups with different symbols, p < 0.01. E &F) circulating number of CXCR4+ cells at 18 h and day 21. At 18 h,* vs. other groups with different symbols, p < 0.001. G &H) circulating number of CD31+ cells. By day 21,* vs. other groups with different symbols, p < 0.001. Statistical analysis in each group by ANOVA followed by Bonferroni multiple comparison post hoc test. CLI = critical limb ischemia; Cil = cilostazol; Clo = clopidogrel.

Back to article page